•
Dec 31, 2017

Cocrystal Pharma Q4 2017 Earnings Report

EPS
-$0.02
Previous year: -$3.06
-99.3%
Cash and Equivalents
$748K
Previous year: $3.61M
-79.3%
Free Cash Flow
-$1.58M
Previous year: -$2.3M
-31.4%
Total Assets
$121M
Previous year: $125M
-2.8%

Cocrystal Pharma

Cocrystal Pharma